Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-28

FDA Approved: OMEPRAZOLE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approved Aurohealth LLC's original ANDA for omeprazole, enabling the marketing of a generic proton pump inhibitor in the United States. It is used to treat …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

ORIG AP for OMEPRAZOLE (OMEPRAZOLE)